LGND ▼ -0.0% - Ligand Pharmaceuticals Incorporated $LGND - Primrose Bio® Raises Significant Growth Capital Investment Led by Signet Healthcare Partners Ligand Pharmaceuticals' stock was flat today despite Primrose Bio, in which Ligand holds a stake, announcing it had secured significant growth capital funding led by Signet Healthcare Partners. The investment could support Primrose Bio's development and commercial efforts, though the headline did not specify the funding amount or immediate impact on Ligand's financials. 22-SEP-2026 09:05 AM ET